Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant ta...
Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Antibodies have been explored extensively as a potential therapeutic for Alzheimer’s disease, where amyloid-β (Aβ) peptides and the tau protein deposit in patient brains. While the major focus of antibody-based therapy development was on Aβ, arguably with limited success in clinical trials, targeting tau has become an emerging strategy, possibly ex...
Alternative Titles
Full title
Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7542fd4f0b3143c8a94362ae7f8f1328
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7542fd4f0b3143c8a94362ae7f8f1328
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-020-70845-x
